Please select the option that best describes you:
What "adjuvant" therapy would you consider in patients with gallbladder cancer with liver metastases that are resected upfront?
Would you use immunotherapy based on the TOPAZ trial?
Answer from: Medical Oncologist at Academic Institution
The scenario is that of already metastatic disease. Adjuvant therapy does not apply. The only choice is patience, hoping for no recurrence. While knowing recurrence is definite, would wait to treat when recurrence occurs. Close monitoring and support would be best!
Sign in or Register to read more
Answer from: Medical Oncologist at Academic Institution
The TOPAZ regimen would not be appropriate here given that the eligible population had unresectable metastatic cholangiocarcinoma. A critical part of the TOPAZ regimen is the ability to carefully monitor the patient for response or progression which, in the adjuvant setting cannot be done. One could...